References
- Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro and nanoparticles in drug delivery. Journal of Controlled Release 2004; 100: 5–28
- Aspden TJ, Mason JD, Jones NS, Lowe J, Skaugrud Ø, Illum L. Chitosan as a nasal delivery system: The effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers. Journal of Pharmaceutical Science 1997; 86: 509–513
- Borchard G, Lueβen HL, De Boer GA, Coos Verhoef J, Lehr CM, Junginger HE. The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption III: Effects of chitosanglutamate and carbomer on epithelial tight junctions in vitro. Journal of Controlled Release 1996; 39: 131–138
- Calvo P, Remuňán-Lòpez C, Vila-Jato JL, Alonso MJ. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. Journal of Applied Polymer Science 1997; 63: 125–132
- Dang JM, Leong KW. Natural polymers for gene delivery and tissue engineering. Advanced Drug Delivery Reviews 2006; 58: 487–499
- Felt O, Buri P, Gurny R. Chitosan: A unique polysaccharide for drug delivery. Drug Delivery and Industrial Pharmacy 1998; 24: 979–993
- Freitas RA, Jr. What is nanomedicine?. Nanomedicine 2005; 51: 325–341
- Gan Q, Wang T, Cochrane C, McCarron P. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids and Surfaces B: Biointerfaces 2005; 44: 65–73
- Grieser F, Ashokkumar M, Sostaric JZ. Sonochemistry and sonoluminescence in colloidal systems. Sonochemistry and sonoluminescence NATO ASI Series, LA Crum, TJ Mason, JL Reisse, KS Suslik. Kluwer Academic Publishers, Netherlands 1999; 345–362
- Hartree EE. Determination of protein: A modification of Lowry method that gives a linear photometric response. Analytical Biochemistry 1972; 48: 422–427
- Janes KA, Calvo P, Alonso MJ. Polysaccharide colloidal particles as delivery systems for macromolecules. Advanced Drug Delivery Reviews 2001; 47: 83–97
- McNeela EA, O'connor D, Jabbal-Gill I, Illum L, Davis SS, Pizza M, Peppoloni S, Rappuoli R, Mills KHG. A mucosal vaccine against diphtheria: Formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery. Vaccine 2001; 19: 1188–1198
- Muzzarelli RAA. Colorimetric determination of chitosan. Analytical Biochemistry 1998; 260: 255–257
- Onishi H, Machida Y. Biodegradation and distribution of water-soluble chitosan in mice. Biomaterials 1999; 20: 175–182
- Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cell and tissue. Advanced Drug Delivery Reviews 2003; 55: 329–347
- Peppas NA, Huangy Y. Nanoscale technology of mucoadhesive interactions. Advanced Drug Delivery Reviews 2004; 56: 1675–1687
- Rao SB, Sharma CP. Use of chitosan as a biomaterial: Studies on its safety and hemostatic potential. Journal of Biomedical Material Research 1997; 34: 21–28
- Sinha VR, Trehan A. Biodegradable microspheres for protein delivery. Journal of Controlled Release 2003; 90: 261–280
- Tang ESK, Huang M, Lim LY. Ultrasonication of chitosan and chitosan nanoparticles. International Journal of Pharmaceutics 2003; 265: 103–114
- Viglio S, Annovazzi L, Conti B, Genta I, Perugini P, Zanone C, Casado B, Cetta G, Iadarola P. The role of emergine techniques in the investigation of prolidase deficiency: From diagnosis to the development of a possibile therapeutic approach. Journal of Chromatography B 2006; 832: 1–8